According to Immunovant's latest financial reports the company's current earnings (TTM) are -โน25.05 B. In 2023 the company made an earning of -โน21.28 B a decrease over its 2022 earnings that were of -โน16.05 B.The earnings displayed on this page is the company's Pretax Income.